Observational study supported by the CF Foundation will monitor real-world experience with Trikafta
Site Search
Showing 1 - 3 of 3 results
Press Release
|
|
4 min read
Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance
Press Release
|
|
4 min read
Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.
Press Release
|
|
4 min read